Shares of BKV Corp—a unit of Thailand’s billionaire Vongkusolkit family's Banpu—closed flat in its trading debut on Thursday ...

(Reuters) -Shares of BKV rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas ...

Texas-based Barnett Shale driller prices below the estimated range, while obesity-drug developer BioAge prices midrange ahead ...

Chris Kalnin, BKV CEO, joins 'Money Movers' to discuss the company's IPO today, what investors need to know about the state ...

Obesity-drug developer BioAge Labs Inc. gained about 20% after its initial public offering on Thursday, while natural-gas ...

BKV Corporation, the gas production arm of energy conglomerate Banpu Plc, has started selling its shares under an initial ...

Headlines,BKV made a successful debut on the New York Stock Exchange, achieving a significant market capitalization.,The ...

Obesity-drug developer BioAge Labs Inc. gained nearly 30% after its initial public offering on Thursday, while natural-gas producer BKV Inc.'s rose about 3% over its $18 IPO price. BioAge (BIOA) stock ...

Texas-based Barnett Shale driller BKV Inc. priced below the estimated range, while obesity-drug developer BioAge Labs Inc. priced midrange ahead of their first day of trading on Thursday. As the ...

Japanese conglomerate Mitsubishi will acquire a 10% stake in a Sarawak natural gas liquefaction facility run by Malaysian state energy firm Petroliam Nasional for a ten-year period by the end of 2024, ...

category Natgas producer BKV valued at $1.56 bln in NYSE debut 3:34 PM UTC · Updated ago category Chevron agrees Hess CEO ...

The U.S. IPO market has bounced back strongly in 2024 after a nearly two-year dry spell, driven by receding recession fears ...